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INTRODUCTION
Great progress has been made over the last five decades in the
treatment of cancer in children. This has been due to the
development of more effective combined modality treatments,
and their systematic testing by consortia of institutions and
cooperative clinical trials. The results have been extraordinary
with gratifying increases in the survival rates for children with most
of the pediatric malignant diseases.
The treatments employed were two-edged, however. Growth
retardation after irradiation had been demonstrated in the early
1900’s [1], but the short- and long-term complications of
chemotherapy also had to be identified and defined. These
iatrogenic early and late somatic effects became a matter of
increasing concern. In addition, attention needed to be paid to the
psychosocial and economic areas. These holistic concerns were
encapsulated in the slogan, “Cure is not enough,” promulgated in
the 1970’s [2]. The focus of pediatric oncology shifted from, “Cure
at any price” when survival rates were dismal, to “Cure at least
price” as effective, targeted therapies evolved. The goal became to
secure long-term, complication-free survival; thus, quality of life
measures became included among the major criteria of success.
These aspects of care formed the first paradigm of pediatric
oncology.
Some pediatric centers understood that somatic complications
were not the only late effects to be avoided. They therefore
embraced and applied a holistic, comprehensive approach to
childhood cancer patients and their families [3]. Relevant research
papers began to appear with increasing frequency in the 1990’s.
These documented the continuing psychosocial difficulties and
post-traumatic stress symptoms experienced by many long-term
survivors. Multidisciplinary teams that included family members
were established. These were meant to respond to the educational,
psychological, emotional, and social concerns of the child.
However, as Parry and Chesler pointed out, “Most researchers
have focused primarily on the negative psychosocial sequela of
childhood cancer, suggesting that … survivors manifest posttrau-
matic stress disorder (PTSD) [4]. The assumption that survivors of
childhood cancer necessarily develop serious psychosocial
difficulties or even psychopathology is not correct according to
Parry and Chesler. While some patients indeed continue to suffer,
most are resilient. They endure the temporary upheaval of a serious
life-threatening disease, achieve or return to a normal level of
psychosocial functioning, and move on to new life challenges.
By the 2000s, research had established the resilience of long-
term survivors even for those who develop one or more subsequent
malignancies [5]. Furthermore; recognition of post-traumatic stress
gave rise to an interest in a potential corollary, post-traumatic
growth (PTG). The term indicates that traumatic life events can
elicit positive life changes or benefits in spite of the distressing
episode [6]. Articles describing the cancer experience as a catalyst
for psychosocial growth mostly appeared in the psychology
literature. That literature, not often perused by medical or pediatric
oncologists, includes concrete examples. Survivors often credited
their cancer experience with helping them achieve greater
psychological maturity, deepened personal and social relationships,
and a new sense of meaning in their lives [4]. One report of 150
adolescent survivors of childhood cancer aged 11–19 years at least
1 year post-treatment is of interest. Of the150, 127 (84.7%)
identified at least one positive consequence of having had cancer
and 32% cited four or more benefits [7]. Other studies reported
associations between older age at diagnosis and PTG or “benefit-
finding [8–10].” These data suggest that having the cognitive
capacity to identify one’s experience as traumatic is a necessary
precursor to manifesting PTG. In a study of 132 young adult
survivors of high-grade osteosarcoma diagnosed before 20 years of
age, those who experienced amputation (as opposed to limb surgery
or no surgery) were more likely to report PTG [9]. This argues that
the more severe the trauma, the higher the probability of post-
traumatic growth. This observation is supported by the theoretical
and empirical literature on PTG in other settings and other
populations (survivors of war, terror, and sexual abuse). Individuals
must first experience and acknowledge significant psychological
trauma in order to be able to supervene and grow therefrom. The
results of studies with regard to the association between race and
gender and PTG are mixed. Some have identified a greater
likelihood of reporting PTG by people of color [8,10] and
females [8]. Thus, some individuals who have experienced
discrimination may be better able to cope with or overcome other
adverse situations. The literature on alleviation of posttraumatic
effects lists other helpful factors. These include supportive families
and friends, time and the ability to reflect on the experience, and
access to counseling. A problem-solving coping style, too, may
contribute to growth. Thus, the message is not “what you have,” but
“what you make of it.”
Pediatric oncologists have not paid particular attention to
resilience or PTG, and little has been done to encourage it. Existing
evidence nonetheless calls for further clinical and research
attention. Meanwhile, discussion of these favorable possibilities
could instill hope in survivors. Such discussions should not,
however, hold out unreal or inappropriate expectations nor should
parental or physician pressure be imposed. Rather, subtle, common-
sense means can be employed. For example, potential patient
resilience can be exemplified by photographs of sports or other
celebrities who have survived cancer mounted on clinic walls.
1Department of Pediatrics, University of Milan-Bicocca, Fondazione
MBBM,Monza, Italy; 2School of SocialWork, University ofMichigan,
Ann Arbor, Michigan; 3Department of Radiation Oncology, University
of Pennsylvania, Philadelphia, Pennsylvania
*Correspondence to: Giuseppe Masera, Department of Pediatrics,
University of Milan-Bicocca Fondazione MBBM Via Pergolesi, 33
20900 Monza, Italy. E-mail: g.masera@hsgerardo.org
Received 5 December 2012; Accepted 24 January 2013
C 2013 Wiley Periodicals, Inc.
DOI 10.1002/pbc.24504
Published online 22 March 2013 in Wiley Online Library
(wileyonlinelibrary.com).
Future investigations can proceed along two fronts. One is
quantitative research through appropriately designed question-
naires. The other is qualitative and depends on the use of interviews
and narratives. In both cases new measures are needed. Care must
also be taken since reports of resilience and PTG can be confused.
Assessments of PTG, as in some studies of post-traumatic stress
studies [11], can be undertaken 6 months to 1 year after diagnosis.
Evaluations can also be considered for later key time points,
including the transition to off-treatment or 5-year or other long-term
survival interval.
Counseling to offset PTSD and other negative psychological
late-effects is certainly needed. The remarkable PTG experienced
by some long-term survivors should, however, be fostered and given
the prominence it certainly deserves. Awareness can be enhanced
by inclusion of PTG on the agendas of relevant scientific
committees, meeting programs and in long-term follow-up guide-
lines. These should encompass not only late complications, but also
PTG as a positive late-effect.
It has become the second paradigm of pediatric oncology.
Realization of its importance should strengthen the bonds between
pediatric oncologists and psychologists, and thus improve clinical
care and stimulate collaborative research.
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